Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lindsay Kilburn, MD
Children's National Research Institute
Study Chair - Margaret Shatara, MD
Children's Minnesota
Study Chair - Megan Paul, MD
Rady Children's Hospital, San Diego
Study Chair - Robert Wechsler-Reya, PhD
Columbia University
Study Chair - Sabine Mueller, MD, PhD, MAS
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
Ashley Margol, MDTom Belle Davidson, MDRecruiting - Rady Children'S Hospital
San Diego, California, United States
Jennifer Elster, MDMegan Paul, MDRecruiting - University of California, San Francisco
San Francisco, California, United States
Alyssa Reddy, MDSabine Mueller, MD, PhDRecruiting - Children'S National Hospital
Washington D.C., District of Columbia, United States
Lindsay Kilburn, MDRoger Packer, MDRecruiting - St. Louis Children'S Hospital / Washington University in St. Louis
St Louis, Missouri, United States
Andrew Cluster, MDMohamed Abdelbaki, MDRecruiting - Columbia University Medical Center
New York, New York, United States
James H Garvin Jr., MDRecruiting - New York University
New York, New York, United States
Recruiting - Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Cassie Kline, MD, MASJane Minturn, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Feb 2022
- Primary completion
- 31 Dec 2027
- Completion
- 31 Jan 2028
- Last update posted
- 15 Apr 2026
- Registered enrollment
- 74
- Registry id
- NCT05057702
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.